Sector consensus DexCom, Inc. Xetra

Stocks

Market Closed - Xetra 11:35:36 2026-10-02 EDT			5-day change	1st Jan Change
76.40 ^EUR	-0.52%		-0.26%	+33.19%

10-01	RBC Raises Price Target on DexCom to $105 From $90, Keeps Outperform Rating	MT
09-28	Dexcom Publishes New Report During Easd 2026 on Type 2 Diabetes Revealing Critical Opportunity for Global Diabetes Care	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' target price evolution (4 months)	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Average Target P.	Objective/dr gap	Nbr of analysts
DEXCOM, INC.	-	-	-	-	-	-	-
ABBOTT LABORATORIES					120.58	+23.68%	25
MEDTRONIC PLC					104.83	+21.36%	24
STRYKER CORPORATION					367.8	+33.54%	25
ESSILORLUXOTTICA					232.61	+62.89%	23
CENCORA, INC.					369.25	+19.48%	12
HOYA CORPORATION					30,200	+24.9%	15
BECTON, DICKINSON AND COMPANY					195.67	+10.67%	12
IDEXX LABORATORIES, INC.					701.33	+35.29%	12
DEXCOM, INC.					95.08	+11.39%	25
ALCON INC.					91.32	+43.31%	17
MEDLINE INC.					44.54	+25.07%	26
WEST PHARMACEUTICAL SERVICES, INC.					407.56	+11.67%	16
GUARDANT HEALTH, INC.					197.44	+11.05%	25
SARTORIUS STEDIM BIOTECH					237.29	+13.97%	14
TERUMO CORPORATION					3,121.54	+39.14%	13
STERIS PLC					263.12	+26.17%	8
SONOVA HOLDING AG					235.68	-5.12%	19
STRAUMANN HOLDING AG					113.05	+25.89%	19
ZIMMER BIOMET HOLDINGS, INC.					107.57	+21.84%	21
Average					1,958.22	+24.01%	18
Weighted average by Cap.					1,964.76	+26.55%	20